The patent covers methods, systems, compositions, and kits for the multiplexed detection of analytes in a sample.

Bio-Rad Laboratories, Inc. BIO recently entered into a binding agreement to purchase all equity interests in Stilla Technologies ("Stilla"). Stilla’s next-generation digital PCR solutions complement ...

Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to ...

Latin Times The company behind a successful AI assistant is requiring job applicants to write their application without the help of an AI assistant. Anthropic, responsible for the popular AI ...

Request To Download Free Sample of This Strategic Report@ Highlighted with 25 tables and 60 figures, this 131-page report North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product ...

SAN FRANCISCO, Feb 5 (Reuters) - Google (GOOGL.O), opens new tab aims to release commercial quantum computing applications within five years, Google's head of quantum told Reuters on Wednesday ...